Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Strategic Review

14 Mar 2024 07:00

RNS Number : 7782G
Amati AIM VCT PLC
14 March 2024
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICITON WHERE TO DO SO WOULD COSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THE JURISDICITON.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATON FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. ON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

For immediate release

14 March 2024

Amati AIM VCT plc

 

Strategic review

 

The Board of Amati AIM VCT plc (the "Company") confirms that it has, in conjunction with the Company's investment manager, Amati Global Investors Limited (the "Investment Manager"), been considering the Company's strategic options in the light of ongoing challenges in the AIM market and the resultant performance issues faced by the Company. As part of this review, the Board intends to consider whether the Company's investment strategy should be expanded to facilitate investment in a broader range of securities while continuing to comply with the rules applicable to VCTs. 

 

The Board also notes the recent announcement of a recommended offer (the "Offer") for Mattioli Woods plc by Tiger Bidco Limited (owned by funds managed by Pollen Street Capital Limited). Mattioli Woods plc currently owns 49% of the issued share capital of the Investment Manager. The ongoing review of strategic options will take into account any possible impact of the Offer on the Company and the management of its investment portfolio.

 

Further details of the strategic review will be included in the Company's annual report and accounts which are expected to be published shortly.

 

Enquiries:

 

Fiona Wollocombe, Chair

Amati AIM VCT plc

Email: info@amatiglobal.com

 

Douglas Armstrong

Dickson Minto Advisers

Financial Adviser to the Company

Telephone: 020 7649 6823

 

Important Information

This announcement is released by the Company and the information contained within this announcement is deemed by the Company to constitute inside information for the purposes of Article 7 of the UK version of the EU Market Abuse Regulation (Regulation (EU) No.596/2014) which forms part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended. Upon the publication of this announcement via a Regulatory Information Service, such information is now considered to be in the public domain.

Legal Entity Identifier (LEI): 213800HAEDBBK9RWCD25

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDSFMFUDELSEID
Date   Source Headline
1st Aug 20232:51 pmRNSTransaction in Own Shares
1st Aug 20239:47 amRNSTotal Voting Rights
24th Jul 20232:45 pmRNSDirector/PDMR Shareholding
21st Jul 20234:31 pmRNSIssue of Equity - DRIS
21st Jul 20233:41 pmRNSNet Asset Value(s)
14th Jul 20235:28 pmRNSNet Asset Value(s)
11th Jul 20234:46 pmRNSTransaction in Own Shares
7th Jul 20235:30 pmRNSNet Asset Value(s)
6th Jul 202312:47 pmRNSTransaction in Own Shares
4th Jul 202310:10 amRNSNet Asset Value(s)
3rd Jul 202310:56 amRNSTotal Voting Rights
26th Jun 202311:43 amRNSNet Asset Value(s)
23rd Jun 20234:41 pmRNSTransaction in Own Shares
19th Jun 20239:14 amRNSNet Asset Value(s)
15th Jun 20232:34 pmRNSResult of AGM
9th Jun 20235:18 pmRNSNet Asset Value(s)
2nd Jun 202310:44 amRNSNet Asset Value(s)
1st Jun 202310:32 amRNSTotal Voting Rights
26th May 20234:01 pmRNSNet Asset Value(s)
22nd May 20232:11 pmRNSNet Asset Value(s)
15th May 20235:06 pmRNSTransaction in Own Shares
15th May 20239:36 amRNSNet Asset Value(s)
5th May 20233:56 pmRNSNet Asset Value(s)
3rd May 202311:17 amRNSNet Asset Value(s)
2nd May 20238:55 amRNSTotal Voting Rights
26th Apr 20231:14 pmRNSTransaction in Own Shares
24th Apr 20234:15 pmRNSNet Asset Value(s)
18th Apr 202311:44 amRNSTransaction in Own Shares
18th Apr 20237:01 amRNSDividend Declaration
18th Apr 20237:00 amRNSAnnual Financial Report
14th Apr 20233:26 pmRNSNet Asset Value(s)
6th Apr 20235:01 pmRNSNet Asset Value(s)
4th Apr 20239:25 amRNSNet Asset Value(s)
3rd Apr 202311:52 amRNSTransaction in Own Shares
3rd Apr 20239:36 amRNSTotal Voting Rights
24th Mar 20235:18 pmRNSNet Asset Value(s)
17th Mar 20235:04 pmRNSNet Asset Value(s)
17th Mar 20232:56 pmRNSCompliance with Market Abuse Regulation
15th Mar 20232:47 pmRNSTransaction in Own Shares
14th Mar 202311:34 amRNSTransaction in Own Shares
10th Mar 20235:26 pmRNSNet Asset Value(s)
8th Mar 202312:43 pmRNSTransaction in Own Shares
1st Mar 20234:34 pmRNSNet Asset Value(s)
1st Mar 20239:06 amRNSTotal Voting Rights
24th Feb 20235:31 pmRNSNet Asset Value(s)
24th Feb 202311:57 amRNSTransaction in Own Shares
21st Feb 202311:07 amRNSTransaction in Own Shares
20th Feb 202311:18 amRNSNet Asset Value(s)
14th Feb 20233:15 pmRNSTransaction in Own Shares
10th Feb 20234:04 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.